395 related articles for article (PubMed ID: 33343579)
1. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
Front Immunol; 2020; 11():605688. PubMed ID: 33343579
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
[TBL] [Abstract][Full Text] [Related]
4. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
Front Immunol; 2022; 13():769900. PubMed ID: 35185875
[TBL] [Abstract][Full Text] [Related]
5. A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G.
Mocci S; Littera R; Chessa L; Campagna M; Melis M; Ottelio CM; Piras IS; Lai S; Firinu D; Tranquilli S; Mascia A; Vacca M; Schirru D; Lecca LI; Rassu S; Cannas F; Sanna C; Carta MG; Sedda F; Giuressi E; Cipri S; Miglianti M; Perra A; Giglio S
Front Immunol; 2023; 14():1138559. PubMed ID: 37342325
[TBL] [Abstract][Full Text] [Related]
6. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
[TBL] [Abstract][Full Text] [Related]
7. A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population.
Mocci S; Littera R; Tranquilli S; Provenzano A; Mascia A; Cannas F; Lai S; Giuressi E; Chessa L; Angioni G; Campagna M; Firinu D; Del Zompo M; La Nasa G; Perra A; Giglio S
Front Immunol; 2022; 13():891147. PubMed ID: 35514995
[TBL] [Abstract][Full Text] [Related]
8. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; López-Ruz MÁ; Martín-Casares AM; Fernández-Rubiales A; Anderson P; Garrido F; Ruiz-Cabello F; López-Nevot MÁ
J Microbiol Immunol Infect; 2022 Jun; 55(3):421-427. PubMed ID: 34475005
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients.
Ebrahimi S; Ghasemi-Basir HR; Majzoobi MM; Rasouli-Saravani A; Hajilooi M; Solgi G
Hum Immunol; 2021 Oct; 82(10):719-725. PubMed ID: 34294460
[TBL] [Abstract][Full Text] [Related]
10. HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population.
Mariaselvam CM; Fortier C; Charron D; Krishnamoorthy R; Tamouza R; Negi VS
HLA; 2016 Nov; 88(5):253-258. PubMed ID: 27753285
[TBL] [Abstract][Full Text] [Related]
11. HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study.
Lagha A; Messadi A; Boussaidi S; Kochbati S; Tazeghdenti A; Ghazouani E; Almawi WY; Yacoubi-Loueslati B
HLA; 2016 Sep; 88(3):100-9. PubMed ID: 27580864
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
Qi J; Wang TJ; Li HX; Wu D; Du D; Wu JH; Shang LX; Chen L; Wang MN; Wang XF
Hum Immunol; 2020 Dec; 81(12):685-691. PubMed ID: 32693929
[TBL] [Abstract][Full Text] [Related]
13. Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.
Cocco E; Murru R; Costa G; Kumar A; Pieroni E; Melis C; Barberini L; Sardu C; Lorefice L; Fenu G; Frau J; Coghe G; Carboni N; Marrosu MG
PLoS One; 2013; 8(4):e59790. PubMed ID: 23593151
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19.
Astbury S; Reynolds CJ; Butler DK; Muñoz-Sandoval DC; Lin KM; Pieper FP; Otter A; Kouraki A; Cusin L; Nightingale J; Vijay A; Craxford S; Aithal GP; Tighe PJ; Gibbons JM; Pade C; Joy G; Maini M; Chain B; Semper A; Brooks T; Ollivere BJ; McKnight Á; Noursadeghi M; Treibel TA; Manisty C; Moon JC; ; Valdes AM; Boyton RJ; Altmann DM
Immunology; 2022 May; 166(1):68-77. PubMed ID: 35156709
[TBL] [Abstract][Full Text] [Related]
15. The influence of HLA genotype on the severity of COVID-19 infection.
Langton DJ; Bourke SC; Lie BA; Reiff G; Natu S; Darlay R; Burn J; Echevarria C
HLA; 2021 Jul; 98(1):14-22. PubMed ID: 33896121
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population.
Lara-Marquez ML; Yunis JJ; Layrisse Z; Ortega F; Carvallo-Gil E; Montagnani S; Makhatadze NJ; Pocino M; Granja C; Yunis E
Clin Exp Allergy; 1999 Jan; 29(1):60-71. PubMed ID: 10051703
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.
Samaranayake N; Fernando SD; Neththikumara NF; Rodrigo C; Karunaweera ND; Dissanayake VH
BMC Infect Dis; 2016 Jun; 16():292. PubMed ID: 27301744
[TBL] [Abstract][Full Text] [Related]
18. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.
Amoroso A; Magistroni P; Vespasiano F; Bella A; Bellino S; Puoti F; Alizzi S; Vaisitti T; Boros S; Grossi PA; Trapani S; Lombardini L; Pezzotti P; Deaglio S; Brusaferro S; Cardillo M;
Transplantation; 2021 Jan; 105(1):193-200. PubMed ID: 33141807
[TBL] [Abstract][Full Text] [Related]
19. Study of HLA class II loci reveals DQB1*03:03:02 as a risk factor for asthma in a Pakistani population.
Saba N; Raja GK; Yusuf O; Rehman S; Munir S; Sajjad S; Mansoor A
Int J Immunogenet; 2022 Dec; 49(6):372-378. PubMed ID: 36271816
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso.
Ouedraogo AR; Traoré L; Ouattara AK; Ouedraogo AR; Zongo SV; Savadogo M; Lallogo TD; Sombie HK; Sorgho PA; Ouedraogo TC; Djigma FW; Lamien AS; Yonli AT; Lompo OM; Simporé J
BMC Med Genomics; 2023 Oct; 16(1):246. PubMed ID: 37845715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
